Sponsor:
Sagimet Biosciences Inc.
Code:
NCT07863193
Conditions
Acne Vulgaris
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Denifanstat
Placebo
Brief summary:
Conditions
Acne Vulgaris
Study ID
NCT07863193
Start date
Oct 21, 2026
Status verified date
Nov, 2026
Completion date
Apr, 2028
Anticipated
Primary completion date
Aug, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Enrollment
800 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Denifanstat
placebo comparator: Placebo
Interventions
Denifanstat
Placebo
Primary outcome measure
Central contacts
Locations
Sagimet Investigative Site
Recruiting
Bryant, Arkansas, United States, 72022
Sagimet Investigative Site
Recruiting
Beverly Hills, California, United States, 90211
Sagimet Investigative Site
Recruiting
Fremont, California, United States, 94538
Sagimet Investigative Site
Recruiting
San Diego, California, United States, 92123
Sagimet Investigative Site
Recruiting
Santa Ana, California, United States, 92705
Sagimet Investigative Site
Recruiting
Doral, Florida, United States, 33126
Sagimet Investigative Site
Recruiting
Fort Lauderdale, Florida, United States, 33308
Sagimet Investigative Site
Recruiting
Miami, Florida, United States, 33125
Sagimet Investigative Site
Recruiting
Miami, Florida, United States, 33126
Sagimet Investigative Site
Recruiting
Miami, Florida, United States, 33155
Sagimet Investigative Site
Recruiting
Miami, Florida, United States, 33175
Sagimet Investigative Site
Recruiting
Miramar, Florida, United States, 33027
Sagimet Investigative Site
Recruiting
Sweetwater, Florida, United States, 33182
Sagimet Investigative Site
Recruiting
Lincolnshire, Illinois, United States, 60069
Sagimet Investigative Site
Recruiting
Indianapolis, Indiana, United States, 46250
Sagimet Investigative Site
Recruiting
New Albany, Indiana, United States, 47150
Sagimet Investigative Site
Recruiting
Plainfield, Indiana, United States, 46168
Sagimet Investigative Site
Recruiting
Brighton, Massachusetts, United States, 02135
Sagimet Investigative Site
Recruiting
Ann Arbor, Michigan, United States, 48103
Sagimet Investigative Site
Recruiting
Clinton Township, Michigan, United States, 48038
Sagimet Investigative Site
Recruiting
Saint Joseph, Missouri, United States, 64506
Sagimet Investigative Site
Recruiting
Omaha, Nebraska, United States, 68144
Sagimet Investigative Site
Recruiting
Portsmouth, New Hampshire, United States, 03801
Sagimet Investigative Site
Recruiting
Robbinsville, New Jersey, United States, 08691
Sagimet Investigative Site
Recruiting
Wilmington, North Carolina, United States, 28045
Sagimet Investigative Site
Recruiting
Columbus, Ohio, United States, 43215
Sagimet Investigative Site
Recruiting
East Greenwich, Rhode Island, United States, 02818
Sagimet Investigative Site
Recruiting
Greenville, South Carolina, United States, 29615
Sagimet Investigative Site
Recruiting
Murfreesboro, Tennessee, United States, 37130
Sagimet Investigative Site
Recruiting
Nashville, Tennessee, United States, 37215
Sagimet Investigative Site
Recruiting
College Station, Texas, United States, 77845
Sagimet Investigative Site
Recruiting
El Paso, Texas, United States, 79902
Sagimet Investigative Site
Recruiting
Houston, Texas, United States, 77055
Sagimet Investigative Site
Recruiting
San Antonio, Texas, United States, 78215
Sagimet Investigative Site
Recruiting
Spokane, Washington, United States, 99202
Sponsor
Sagimet Biosciences Inc.
Last update posted
Nov 19, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-22. This information was provided to ClinicalTrials.gov by Sagimet Biosciences Inc. on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.